17 COVID-19 Government Funding Resources & Application Deadlines

The federal agencies and departments that participate in the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are providing daily updates to information and deadlines in reaction to the impact of the COVID-19 pandemic.

Below is a list of important deadlines as of April 13, 2020. The pages referenced are updated frequently. We recommend that companies make it a regular practice to visit the pages that affect existing projects and grants, as well as applications and new opportunities daily.

Participating agencies strongly encourage all existing grantees to engage with their contracting/agreements officer to determine what measures can be taken in the event contract performance is affected due to the COVID-19 situation. Grantees are asked to identify to their contracting/agreements officer potential impacts to the welfare and safety of their workforce and any contract/other transaction (OT) performance issues. Most importantly, keep mind that only a grantee’s contracting/agreements officer can affect changes to your contract/OT.

Additionally, agencies are resetting priorities to identify opportunities for COVID-19 related grants.

Upcoming SBIR/STTR Deadlines

Opportunities with Federal Agencies Related to COVID-19

COVID-19 Opportunities with the Federal Agencies

  • National Institutes of Health (NIH) has a New Urgent Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional: Learn more.
  • The latest information for NIH Funding can be found here. This is a rapidly evolving situation and this page is continually updated with guidance and information as it becomes available, so please refer back to it often.
  • National Science Foundation (NSF) has issued a request for SBIR/STTR Phase I proposals addressing COVID-19. Learn more.
  • Department of Energy (DOE) has requested ideas on COVID-19 research that DOE can support. Learn more.
  • Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) will be queuing all applications that do not apply to DOVID-19. Areas of Interest for COVID-19 include diagnostic assay, POC diagnostic, vaccine, therapeutics, immunomodulators targeting lung repair, pre- and post-exposure prophylaxis, protective devices, ventilators, and more. Learn more.
  • US Air Force COVID-19: Learn more.
  • Air Force Ventures Submission Form: Joint Acquisition Task Force (JATF) COVID-19 Request for Industry/Academia/Non-Government Information. Learn more.
  • Medical Technology Enterprise Consortium (MTEC) Active Solicitations and Presolicitation for COVID-19.
  • DRIVe in partnership with Biomedical Advanced Research and Development Authority (BARDA): EZ BAA: up to $749K, emerging technologies for COVID-19. Learn more.
  • Medical CBRN Defense Consortium: Therapeutics to Treat COVID-19and other medical countermeasures.
  • Homeland Security/Federal Emergency Management Agency (DHS/FEMA) COVID-19 PPE and Medical Supplies: Learn more.
  • National Institute of Standards and Technology (NIST) Manufacturing USA National Emergency Assistance Program Department of Commerce: Learn more.

Please contact your Rev1 advisor if we can be of assistance and provide additional information.